Arthneeti
Sale is live|00:00:00

Huhtamaki India Ltd Q1 FY27 Earnings Analysis

Published 5 Jul 2026 | Industrial Products | Market Cap: ₹1.2K Cr

Price

216

Market Cap

₹1.2K Cr

P/E Ratio

10.6

Revenue Rank

Rank 4

Margin Rank

Rank 3

Earnings Summary

- Company sees enough demand and market opportunity aligned with their value proposition for organic growth; no current plans for inorganic expansion. - The company is focused on **profitable growth** with a strong strategy aligning with customer needs, innovation, and operational efficiency.

📊 Revenue & Sales Performance

Rank 4

- Company sees enough demand and market opportunity aligned with their value proposition for organic growth; no current plans for inorganic expansion. - Capacity utilization is not a constraint, with substantial room to grow volumes. - Targeting profitable growth through selective participation in higher-value, innovation-led segments. - Focus on premiumization, sustainability, and innovation with select multinational customers to drive growth. - Market growth varies by segment; smaller regional players grow faster, but company is focused on segments aligned with its strengths. - Inflation impacts revenue positively due to cost pass-through but has minimal impact on margins. - Demand is stabilizing post-war, with growth expected in line with FMCG customers’ typical annual increases (~2-7%). - Growth momentum expected from operational efficiencies and improved EBIT margins returning to historic levels (~8%).

📈 Profitability & Margins

Rank 3

- The company is focused on **profitable growth** with a strong strategy aligning with customer needs, innovation, and operational efficiency. (Page 4, 9, 12) - EBITDA margins have shown **consistent improvement** with sequential growth and a 25% increase year-on-year in the recent quarter, reflecting effective strategic implementation. (Page 4) - EBIT margins improved to around 8%, showing momentum towards returning to strong profitability levels. (Page 4) - EPS showed a slight decrease recently due to one-off prior period depreciation, but underlying profits are growing. (Page 4) - Management expects **ongoing improvement in return on capital**, with better valuations as EPS and profitability improve. (Page 13) - Capacity utilization is currently not a constraint, indicating room for organic growth without immediate inorganic expansion. (Page 12) - Profit margins are expected to remain protected despite raw material inflation due to transparent cost pass-throughs. (Page 12) - No immediate plans for inorganic growth; focus remains on strengthening existing operations and capturing market opportunities. (Page 12)

🏗️ Capital Expenditure Plans

No

- No explicit mention of current or planned capex/capital investment was made in the provided transcript. - Management highlighted focusing on strengthening the organization and operations organically rather than pursuing inorganic growth or acquisitions at this time. - A solar captive electricity project for the Khopoli plant was formalized and is expected to go live in the second half of the year, reflecting a capital investment in sustainability initiatives. - Ongoing investments were noted in sustainability efforts, including equipment for solvent consumption reduction and progress towards zero liquid discharge in multiple plants. - The company is prioritizing operational efficiency and expansion within existing capacity rather than new capacity additions; capacity is currently not a constraint. - No mention of strategic acquisitions or large-capex projects beyond sustainability and operational improvements was made.

💰 Fundraising & Capital Structure

No information

- There is no specific mention of any current or future fundraising plans through debt or equity in the provided transcript. - The company discussed an existing ECB loan from the parent company, with part repayment extended to June 2027, but this is not a new fundraising. - The management highlighted a focus on organic growth with ample capacity and no immediate plans for inorganic opportunities or capital raising. - The emphasis is on strengthening operations and capturing market demand without relying on external fundraises at this time. - Any future inorganic or capital raising activities would be considered if suitable opportunities arise, but nothing is currently on the radar.

📋 Order Book & Pipeline

No information

The transcript provided for Huhtamaki India Limited's earnings call does not explicitly mention details regarding the current or expected order book or pending orders. Key discussion points related to business included: - Capacity utilization is not a constraint; there is significant room for growth organically. - Demand is stabilizing post-war with usual industry growth rates seen (5%-7% with some regional customers growing faster). - No specific mention of order backlog or pending orders. - Focus remains on selective, higher-value business aligned with innovation, premiumization, and sustainability. - Discussions on raw material cost inflation and transparent pass-through to customers, but no impact indicated on order inflow. Hence, no direct information on current or expected order book/pending orders is available from the transcript.

Key Metrics

Revenue

Rank 4

Margin

Rank 3

Capex

No

Fundraise

No information

Order Book

No information

Frequently Asked Questions

What were Huhtamaki India Ltd Q1 FY27 results?

- Company sees enough demand and market opportunity aligned with their value proposition for organic growth; no current plans for inorganic expansion. - The company is focused on **profitable growth** with a strong strategy aligning with customer needs, innovation, and operational efficiency.

What is Huhtamaki India Ltd share price analysis?

Huhtamaki India Ltd currently shows a neutral. The stock trades at a P/E of 10.6 with a market cap of ₹1,249. Investors should review the full earnings analysis for detailed insights.

Is Huhtamaki India Ltd planning capital expenditure?

- No explicit mention of current or planned capex/capital investment was made in the provided transcript.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.